Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 10Endometrial Neoplasms 9Vulvar Neoplasms 3Uterine Neoplasms 2Ovarian Neoplasms 2Sentinel Lymph Node Biopsy (SLNB) 1Recurrence 1Recurent Vulvar Carcinoma 1Fallopian Tube Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Cervical Adenocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Paclitaxel 7Cisplatin 6pembrolizumab 5Carboplatin 5Bevacizumab 5liposomal doxorubicin 3Gemcitabine 3trebananib 2niraparib 2interferon gamma-1b 2dostarlimab 2catumaxomab 2atezolizumab 2anlotinib 2Topotecan 2Radiotherapy, Intensity-Modulated 2Ocoxin 2Itraconazole 2Injections 2Hyperthermic Intraperitoneal Chemotherapy 2Drug Therapy 2Docetaxel 2vosaroxin 1vistusertib 1pertuzumab 1peginterferon alfa-2b 1olaparib 1nintedanib 1lanreotide 1epothilone B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Sentinel Lymph Node Biopsy × Gynecologic × Clear all
NCT00315159 2015-01-12

Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.

Women and Infants Hospital of Rhode Island

Phase NA Completed
74 enrolled
Gynecologic

Carcinoma, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡